Artemis: A Randomised Trial Of Bevacizumab With Neoadjuvant Chemotherapy (Nact) For Patients With Her2-Negative Early Breast Cancer-Primary Endpoint, Pathological Complete Response (Pcr).Helena Margaret Earl,Louise Hiller,Clare Blenkinsop,Louise Grybowicz,Anne-Laure Vallier,Jean Abraham,Jeremy Thomas,Elena Provenzano,Luke Hughes-Davies,Karen McAdam,Steve Chan,Rizvana Ahmad,Tamas Hickish,Stephen Houston,Daniel Rea,John M. S. Bartlett,Carlos Caldas,David A. Cameron,Janet Dunn,Richard L Hayward, for ARTemis InvestigatorsJOURNAL OF CLINICAL ONCOLOGY(2014)引用 5|浏览35暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要